A phase II study of carboplatin and paclitaxel in adenocarcinoma of unknown primary

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 28, Issue 2, 2005, Pages 152-156

  El Rayes, Basil F ^a   Shields, Anthony F ^a   Zalupski, Mark ^a   Heilbrun, Lance K ^a   Jain, Vikash ^a   Terry, Damita ^a   Ferris, Ann Marie ^a   Philip, Philip A ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

Carboplatin; Combination chemotherapy; Paclitaxel; Unknown primary

Indexed keywords

CARBOPLATIN; DEXAMETHASONE; DIPHENHYDRAMINE; ONDANSETRON; PACLITAXEL; RANITIDINE;

ADENOCARCINOMA; ADENOCARCINOMA OF UNKNOWN PRIMARY; ADULT; AGED; ANEMIA; AREA UNDER THE CURVE; ARTICLE; BLOOD TRANSFUSION; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; DEHYDRATION; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; FATIGUE; FEMALE; HERPES ZOSTER; HUMAN; INFECTION; MALE; MYALGIA; NAUSEA; NEUROPATHY; NEUTROPENIA; PERITONITIS; PHASE 2 CLINICAL TRIAL; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTOPENIA;

ADENOCARCINOMA; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, UNKNOWN PRIMARY; PACLITAXEL; SURVIVAL ANALYSIS;

EID: 17044388512     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.coc.0000142590.70472.e2     Document Type: Article

References (19)

1. Greco FA, Hainsworth JD. The evolving role of paclitaxel for patients with carcinoma of unknown primary site. Semin Oncol. 1999;26:129-133.
2. Greco FA, Hainsworth JD. Tumors of unknown origin. CA Cancer J Clin. 1992;42:96-115.
3. Hainsworth JD, Greco FA. Treatment of patients with cancer of an unknown primary site. N Engl J Med. 1993;329:257-263.
4. Warner E, Goel R, Chang J, et al. A multicentre phase II study of carboplatin and prolonged oral etoposide in the treatment of cancer of unknown primary site (CUPS). Br J Cancer. 1998;77:2376-2380.
5. Dowell JE, Garrett AM, Shyr Y, et al. A randomized phase II trial in patients with carcinoma of an unknown primary site. Cancer. 2001;91: 592-597.
6. Anderson H, Thatcher N, Rankin E, et al. VAC (vincristine, adriamycin, cyclophosphamide) chemotherapy for metastatic carcinoma from an unknown primary site. Eur J Cancer Clin Oncol. 1983;19:49-52.
7. Fleming TR. One-sample multiple testing procedure for phase II trials. Biometrics. 1982;38:143-151.
8. Cassella G. Refining binomial confidence intervals. Canadian Journal of Statistics. 1987;14:113-129.
9. Mehta C, Patel N. StatXact 5: Statistical Software for Exact Nonparametric Inference, User Manual. Cambridge, MA: Cytel Software Corp; 1999:429-433.
10. Lee ET. Statistical Methods for Survival Data Analysis. New York: Wiley & Sons, Inc; 1992.
11. Abbruzzese JL, Abbruzzese MC, Hess KR, et al. Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients. J Clin Oncol. 1994;12:1272-1280.
12. Hainsworth JD, Johnson DH, Greco FA. Poorly differentiated neuroendocrine carcinoma of unknown primary site. A newly recognized clinicopathologic entity. Ann Intern Med. 1988;109:364-371.
13. Eagan RT, Therneau TM, Rubin J, et al. Lack of value for cisplatin added to mitomycin-doxorubicin combination chemotherapy for carcinoma of unknown primary site. A randomized trial. Am J Clin Oncol. 1987;10:82-85.
14. Milliken ST, Tattersall MH, Woods RL, et al. Metastatic adenocarcinoma of unknown primary site. A randomized study of two combination chemotherapy regimens. Eur J Cancer Clin Oncol. 1987;23:1645-1648.
15. Greco FA, Erland JB, Morrissey LH, et al. Carcinoma of unknown primary site: phase II trials with docetaxel plus cisplatin or carboplatin. Ann Oncol. 2000;11:211-215.
16. Briasoulis E, Kalofonos H, Bafaloukos D, et al. Carboplatin plus paclitaxel in unknown primary carcinoma: a phase II Hellenic Cooperative Oncology Group Study. J Clin Oncol. 2000;18:3101-3107.
17. Greco FA, Burris HA III, Erland JB, et al. Carcinoma of unknown primary site. Cancer. 2000;89:2655-2660.
18. Hainsworth JD, Erland JB, Kaiman LA, et al. Carcinoma of unknown primary site: treatment with 1-hour paclitaxel, carboplatin, and extended-schedule etoposide. J Clin Oncol 1997;15:2385-2393.
19. Greco FA, Burns HA III, Litchy S, et al. Gemcitabine, carboplatin, and paclitaxel for patients with carcinoma of unknown primary site: a Minnie Pearl Cancer Research Network study. J Clin Oncol. 2002;20: 1651-1656.